What is Novavax's royalties — total revenue?

Novavax (NVAX) reported royalties — total revenue of $3.52M in Q1 2026.

What does royalties — total revenue mean?

This metric represents the total gross revenue generated from licensing intellectual property, patents, or proprietary vaccine technology to third-party partners. It reflects the company's ability to monetize its research and development pipeline through passive income streams rather than direct product sales. Growth in this segment indicates successful commercial adoption of the company's technology by external entities.

Novavax NVAX Royalties — Total Revenue

Similar metrics at other companies

GERNRoyalties — Total revenues

$66K-60.5%

ABCLLicensing and royalty revenue — Total Revenue

$191K+14.4%

LGNDRoyalties — Total revenues and income

$42.96M+56.3%

SRPTRoyalty Revenue — Royalty Revenue

$4.18M+5.8%

SUPNRoyalty, licensing, and other revenues — Total revenues

$29.31M+274%

TXGLicense and royalty revenue — Revenue

$947K-94.4%

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's royalties — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's royalties — total revenue?: Novavax (NVAX) reported royalties — total revenue of $3.52M in Q1 2026.
What does royalties — total revenue mean?: This metric represents the total gross revenue generated from licensing intellectual property, patents, or proprietary vaccine technology to third-party partners. It reflects the company's ability to monetize its research and development pipeline through passive income streams rather than direct product sales. Growth in this segment indicates successful commercial adoption of the company's technology by external entities.